-
公开(公告)号:NZ337557A
公开(公告)日:2001-08-31
申请号:NZ33755798
申请日:1998-03-09
Applicant: BASF AG
Inventor: ROMERDAHL CYNTHIA A
IPC: C07D251/30 , A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/53 , A61P35/00 , C07D239/60 , C07D405/12 , C07D409/12
Abstract: 6-substituted 1,2,4a,5a,8a,8b-hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6H-pyrrolo[3',4':4,5]furo[3,2-b]pyrid-8 7H -one derivatives of general formula (I) and their salts, in which: R1 is hydrogen or optionally substituted alkyl, cycloalkyl, arylalkyl, aryl, heteroaryl or herarylalkyl; R2 is hydrogen or optionally substituted alkyl, cycloalkyl or alkoxycarbonyl; Or R1 and R2 together with the atoms to which they are attached represent an optionally substituted 5- or 6-membered ring, which may be optionally interrupted by oxygen, sulphur, sulphoxyl or sulphonyl; R3 represents hydrogen or optionally substituted alkyl, cycloalkyl or alkoxycarbonyl; R4 represents hydrogen or optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heraryl, hetarylalkyl, amino, alkylamino, di-alkylamino or cycloalkylamino; A represents hydroxy, alkoxy, alkenyloxy, alkinyloxy, arylalkyloxy, formyloxy, azido, halogen, aryloxy, hetarylalkyloxy, hetaryloxy, mercapto, alkylthio, alkylsulphonyl, alkenylthio, arylalkylsulphonyl, hetarylalkylthio, hetarylalkylsulphonyl, arylthio, arylsulphonyl, alkyl, alkenyl, alkinyl, aryl, arylalkyl, hetaryl, hetarylalkyl, alkoxycarbonyl, -X-G(=Y)-Q, CHR6=C(=O)-R7 OR, -O-B1; X represents oxygen or sulphur; -G(=Y)- represents carbonyl, thiocarbonyl, sulphoxyl, sulphonyl, -P(O)-O-R5 OR -P(S)-O-R5; Q represents alkyl, alkenyl, alkinyl, cycloalkyl, alkoxy, alkenyloxy, alkinyloxy, aryl arylalkyl, cycloalkyoxy, hetaryl, hetarylalkyl, an optionally substituted cyclic amino group which is attached via the nitrogen atom; R5 represents alkyl; R6 represents hydrogen alkyl, alkoxy, arylalkoxy, alkylthio, cycloalkylthio, arylthio, hetarylaIkylthio; R7 represents optionally substituted alkyl, alkenyl, cycloalkyl, alkylthio, arylthio, aryl, arylalkyl, hetaryl or hetarylalkyl; Or R6 and R 7 together with the atoms to which they are attached represent a 5-, 6- or 7-membered carbocyclic ring, which may optionally be substituted, B represents hydrogen or optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, hetaryl, hetarylalkyl, formyl, alkoxydicarbonyl or a radical from the group consisting of B I, B2, B3 and B4 R8 represents hydrogen or optionally substituted, alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl; R8 and R9 together with the atoms to which they are attached represent an optionally substituted 5- or 6-membered ring, which is optionally interrupted by oxygen, sulphur, sulphoxyl or sulphonyl; R9 and R10 each represent hydrogen, alkyl, alkenyl, cycloalkyl or optionally substituted aryl, arylalkyl, hetaryl or hetarylalkyl; Or R9 and R10 together represent an optionally substituted spirocyclic ring; -G1(=Y1)- represents carboxyl, thiocarboxyl, -C=CH-NO2, -C=CH-CN, -C=N-R11, sulphoxyl, sulphonyl, -P(O)-O-R5 or -P(S)-O-R5, R11 represents hydrogen, hydroxyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, halogenoalkylcarbonyl, alkylsulphonyl, nitro or cyano; Q represents optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, aryl, arylalkyl, hetaryl or hetarylalkyl, or a radical selected from the group consisting of G1 and G2; -G2(=Y2)- may represent carboxyl, thiocarboxyl or sulphonyl; Z represents oxygen, sulphur or -NR13; R12 may, if Z is nitrogen, represent a cyclic amino group, which is attached via a nitrogen atom; R12 and R13 independently of one another represent hydrogen or optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, alkoxycarbonyl, aryl, arylalkyl, hetaryl or hetarylalkyl; R12 and R13 together with the adjacent N atom represent an optionally substituted carbocyclic 5-, 6- or 7-membered ring system or represent a 7- to 10-membered bicyclic ring system, which may optionally be interrupted by oxygen, sulphur, sulphoxyl, sulphonyl, carbonyl, -N-O, -N=, -NR15- or by quarternized nitrogen; R14 represents hydrogen or alkyl; R15 represents hydrogen or optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkylalkyl, alkoxycar, alkylcarbonyl, cycloalkylcarbonyl, cyano, aryl, arylalkyl, hetaryl, hetarylalkyl; The dotted line is absent or represents a single bond. The compounds are useful in combatting endoparasites.
-
公开(公告)号:BR9808263A
公开(公告)日:2000-05-16
申请号:BR9808263
申请日:1998-03-09
Applicant: BASF AG
Inventor: ROMERDAHL CYNTHIA A
IPC: C07D251/30 , A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/53 , A61P35/00 , C07D239/60 , C07D405/12 , C07D409/12
Abstract: This invention provides a method for treating cancer in an individual, wherein the cancer is a tumor in which endothelin is upregulated (e.g. tumors of the prostate, lung, liver, breast, brain, stomach, colon, endometrium, testicle, thyroid, pituatary, bladder, kidney, pancreas and meninges) by administering to the individual an effective amount of a compound of Formula I or Formula Ia, as describe herein.
-
公开(公告)号:ZA982136B
公开(公告)日:1999-09-13
申请号:ZA982136
申请日:1998-03-13
Applicant: BASF AG
Inventor: ROMERDAHL CYNTHIA A
IPC: C07D251/30 , A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/53 , A61P35/00 , C07D239/60 , C07D405/12 , C07D409/12 , A61K , C07D , C07C
Abstract: This invention provides a method for treating cancer in an individual, wherein the cancer is a tumor in which endothelin is upregulated (e.g. tumors of the prostate, lung, liver, breast, brain, stomach, colon, endometrium, testicle, thyroid, pituatary, bladder, kidney, pancreas and meninges) by administering to the individual an effective amount of a compound of Formula I or Formula Ia, as describe herein.
-
公开(公告)号:HRP980126A2
公开(公告)日:1998-12-31
申请号:HRP980126
申请日:1998-03-10
Applicant: BASF AG
Inventor: ROMERDAHL CYNTHIA A
IPC: C07D251/30 , A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/53 , A61P35/00 , C07D239/60 , C07D405/12 , C07D409/12
Abstract: This invention provides a method for treating cancer in an individual, wherein the cancer is a tumor in which endothelin is upregulated (e.g. tumors of the prostate, lung, liver, breast, brain, stomach, colon, endometrium, testicle, thyroid, pituatary, bladder, kidney, pancreas and meninges) by administering to the individual an effective amount of a compound of Formula I or Formula Ia, as describe herein.
-
公开(公告)号:BG102152A
公开(公告)日:1998-09-30
申请号:BG10215297
申请日:1997-12-29
Applicant: BASF AG
Inventor: HAURT ANDREAS , EMLING FRANZ , ROMERDAHL CYNTHIA A
Abstract: The dolastine derivatives have antineoplastic effect. Theyhave the formulaR1R2N-CHX-CO-A-B-D-E-(F)t-K,where R1, R2, A, B, D, E, F, K, X & t have the meanings listed inthe description. The invention also relates to the preparation ofthese compounds.5 claims
-
公开(公告)号:CA2283732A1
公开(公告)日:1998-09-24
申请号:CA2283732
申请日:1998-03-09
Applicant: BASF AG
Inventor: ROMERDAHL CYNTHIA A
IPC: C07D251/30 , A61K31/505 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/53 , A61P35/00 , C07D239/60 , C07D405/12 , C07D409/12
Abstract: This invention provides a method for treating cancer in an individual, wherein the cancer is a tumor in which endothelin is upregulated (e.g. tumors of the prostate, lung, liver, breast, brain, stomach, colon, endometrium, testicle, thyroid, pituitary, bladder, kidney, pancreas and meninges) by administering to the individual an effective amount of a compound of formula (I) or formula (Ia), as described therein.
-
公开(公告)号:TR199701545T1
公开(公告)日:1998-04-21
申请号:TR9701545
申请日:1996-06-03
Applicant: BASF AG
Inventor: HAUPT ANDREAS , EMLING FRANZ , ROMERDAHL CYNTHIA A
Abstract: Novel compounds of the formulaR1R2N-CHX-CO-A-B-D-(E)s-(F)t-(G)U-KIin which R1, R2, A, B, D, E, F, G, K, X, s, t, and u have the meanings stated in the description, and the preparation thereof are described. The novel substances have an antineoplastic effect.
-
-
-
-
-
-